Last updated on September 2018

A Study to Evaluate the Efficacy Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression

Brief description of study

The purpose of this study is to evaluate the efficacy of fixed dosed intranasal esketamine compared to intranasal placebo, as an add-on to an oral antidepressant in Japanese participants with treatment-resistant depression (TRD), in improving depressive symptoms.

Clinical Study Identifier: NCT02918318

Contact Investigators or Research Sites near you

Start Over

Use link at the bottom ...

Hokkaido Prefectural Midorigaoka Hospital
Hokkaido, Japan
  Connect »